首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Articulation of Quality By Design Elements for Product Development and its Unique Applications
【24h】

Articulation of Quality By Design Elements for Product Development and its Unique Applications

机译:产品开发设计元素及其独特应用质量的阐述

获取原文
           

摘要

Quality by Design (QbD) is a methodical approach to pharmaceutical product development that begins with predefined objectives and emphasizes product and process comprehension and process control based on sound science and quality risk management. Pharmaceutical development should lead to the design a quality product and its manufacturing process to meet the QTPP and CQA parameters. To arrive at the robust product development QbD articulation is important which is missing in most of the reviews. This review articulates the QbD elements in the product development. QbD process stars with identification of QTPP and source CQA from QTPP. CMAs and CPPs are derived with risk assessment from the product ingredients and process. Their impact on the CQAs can be studies with DoE tools. The information and knowledge gained from pharmaceutical development studies and manufacturing experience provide scientific understanding to support the design space and control strategy. Product process follows life cycle management approach with continuous improvement. PAT tools are utilized for the online monitoring of the processes. This review paper is dedicated to provide QbD element articulation in product development and its unique applications in the various areas of the product development such as Biotechnology, Nanotechnology products, Nasal products, Inhalation, Injectable products, Targeted drug delivery, complex Solid oral, Transdermal and topical products, Bioavailability and dissolution enhancement, Analytical processes and API manufacturing etc. Current trends in the technical application of the PAT tools are discussed.
机译:设计质量(QBD)是一种用于制药产品开发的方法方法,以预定义的目标开始,并强调基于声音科学和质量风险管理的产品和过程理解和过程控制。药物开发应导致设计优质产品及其制造过程,以满足QTPP和CQA参数。要达到强大的产品开发,QBD关注很重要,这在大多数评论中缺少。此述评在产品开发中阐明了QBD元素。 QBD处理星星,QTPP识别QTPP和来自QTPP的源CQA。 CMAS和CPPS来自产品成分和过程的风险评估。它们对CQAS的影响可以用DOE工具进行研究。来自药物开发研究和制造经验中获得的信息和知识为支持设计空间和控制策略提供科学的理解。产品过程遵循生命周期管理方法,持续改进。 PAT工具用于在线监控过程。本文致力于提供产品开发的QBD元素阐述及其在产品开发的各个领域的独特应用,如生物技术,纳米技术,鼻制品,吸入,可注射产品,靶向药物递送,复杂的固体口服,透皮和透皮和讨论了局部产品,生物利用度和溶出,分析过程和API制造等PAT工具技术应用的当前趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号